RxDoctor Payments Data

Cassandra Wolfinger Franks

Family · Mount Gilead, OHNPI 1366954513

Payments from drug & device makers

$620in general payments, 2019–2025

Across 35 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$172
  • Pfizer$91
  • Novo Nordisk$84
  • Lilly USA, LLC$78
  • Sanofi Pasteur Inc.$45
  • Boehringer Ingelheim$33
  • plus $117 from 5 others

What the payments were for

  • Food & beverage$620100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$620 in reported general payments places this provider in the 60th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$28,267
Medicare patients
112
Services billed
469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide41$49,565
TrulicityDulaglutide36$35,557
JardianceEmpagliflozin20$29,936
EliquisApixaban25$22,642
OzempicSemaglutide20$19,438
XareltoRivaroxaban33$19,140
LinzessLinaclotide13$13,393
Breo ElliptaFluticasone/Vilanterol15$6,241
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$3,178
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$2,885
Atorvastatin Calcium210$2,055
Albuterol Sulfate HfaAlbuterol Sulfate88$1,953
Trazodone Hcl49$1,247
Omeprazole100$1,088
Potassium Chloride33$1,052

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$78$85,12277 claims
Boehringer IngelheimJardiance$33$29,93620 claims
PfizerEliquis$91$22,64225 claims
Novo NordiskOzempic$84$19,43820 claims
AbbVieLinzess$172$13,39313 claims
GSKBreo Ellipta$33$6,24115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,812 family providers in Ohio.

Other family in Mount Gilead

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →